Research
The UROC Innovations Lab seeks to address critical gaps in the understanding, evaluation, and management of inflammatory diseases using basic science and translational approaches with new strategies to identify novel biomarkers for optimized diagnostics and personalized clinical care.
Point-of-Care Testing for Chronic Rhinosinusitis
We are developing and clinically validating minimally invasive sampling and detection technology that can provide accurate, reliable, and timely diagnostic and prognostic information to healthcare providers and patients with chronic rhinosinusitis in an outpatient setting.
Adjuvant Therapy for Solid Tumors
We are synthesizing and evaluating new, safe polymers that potently inhibit chemokine-mediated cancer progression with controlled delivery as a new adjuvant therapy approach to treat locally advanced and metastatic squamous cell carcinomas.
Nanoscale Delivery in Chronic Rhinosinusitis
We are fine-tuning and evaluating new systemic drug delivery platforms, specifically designed to target sinonasal inflammation and overcome barriers to topical administration, while safely administering first-line treatment as a new therapeutic approach to improve patient outcomes in chronic rhinosinusitis.
Improved Surgical Outcomes in Solid Tumor Treatment
We are developing and evaluating new nanoscale systems with targeted delivery for use in fluorescent image (FI)-guided transoral robotic surgery to improve tumor surgical margins and patient outcomes in oropharyngeal squamous cell carcinomas treatment.